Guzi Biotech (02367) is held by its controlling shareholder Juzi Holding, which has increased its holdings by 1.15 million shares.

China Fortune Financial News APP News, Juzi Biotechnology (02367) issued an announcement. The company's board of directors received a notice from the company's controlling shareholder, Juzi Holding Co., Ltd (Juzi Holding), expressing strong confidence in the future development of the company. In order to promote the company's continuous, stable, and healthy development and to safeguard the interests of the general public investors, on September 24 and September 25, 2025, Juzi Holding purchased a total of 1.15 million shares of the company's stock in the market, with a total increase of approximately HK$ 62.9 million (excluding commissions and other expenses).